Article Review: Herbs for Bone Growth Process

Authors

  • Annisa Rizky Faculty of Pharmacy, University of Indonesia, Depok 16424, West Java, Indonesia
    Indonesia
  • Berna Elya Faculty of Pharmacy, University of Indonesia, Depok 16424, West Java, Indonesia
    Indonesia
  • Fadilah Fadilah Department of Medical Chemistry, Faculty of Medicine, University Indonesia, Jakarta 10430, Indonesia
    Indonesia

DOI:

https://doi.org/10.23917/pharmacon.v23i1.7584

Keywords:

Bone Growth, Chondrocytes, Herbs; Osteoblasts, Osteoclasts, Osteocytes

Abstract

The process of bone growth occurs rapidly in childhood and stops when entering the puberty phase. Currently, stunted bone growth, known as stunting, is a health problem in the world. There is no drug that can specifically help bone growth. Likewise, the use of herbal plants for bone growth is still limited, so further research needs to be carried out to explore plants that have benefits to help increase bone growth. For this reason, the aim of writing this review article is as a basis for identifying herbal plants that can influence bone growth. So that the active compounds in related herbal plants can be developed to make new herbal medicinal products for stunted bone growth. Literature was searched using the scientific databases ScienceDirect, Pubmed, MDPI using several keywords "herbal medicine for bones" and "osteogenic activity in herbal plants". The results obtained were 18 articles that met the inclusion criteria. From these 18 articles, 11 active compounds were obtained, namely Osthole, Levistolide A, Calycosin-7-O-β-glucoside, Cistanoside A, Icariin, Naringenin, Wedelolactone, Ugonin L, Ligustroflavone, Ginsenosides, Puerarin which have the potential to help the bone growth process.

Downloads

Download data is not yet available.

Author Biographies

Berna Elya, Faculty of Pharmacy, University of Indonesia, Depok 16424, West Java, Indonesia

Lecturer / Prof. Dr. Berna Elya, MSi. Apt (Faculty of Phaarmacy) Employment

Fadilah Fadilah, Department of Medical Chemistry, Faculty of Medicine, University Indonesia, Jakarta 10430, Indonesia

Research interest in Biochemistry, Bioinformatics, Genetics and Molecular Biology and Chemistry

References

Abd El-Maksoud, A. M., Khairy, S. A., Sharada, H. M., Abdalla, M. S., & Ahmed, N. F. (2017). Evaluation of pro-inflammatory cytokines in nutritionally stunted Egyptian children. Egyptian Pediatric Association Gazette, 65(3), 80–84. https://doi.org/10.1016/j.epag.2017.04.003

Artaria, M. D. (2008). Pertumbuhan tulang. In M. D. Artaria (Ed.), Manusia makhluk sosial biologis (pp. 96–108). Airlangga University Press.

Cooke, D. W., Divall, S. A., & Radovick, S. (2011). Normal and aberrant growth in children. In S. Melmed et al. (Eds.), Williams textbook of endocrinology (12th ed., pp. 964–1073). Elsevier.

Feng, R., Li, X., Yu, H., & Wang, Y. (2019). Ligustroflavone regulates calcium metabolism through calcium-sensing receptor signaling. Phytomedicine, 58, 152889. https://doi.org/10.1016/j.phymed.2019.152889

Feng, Y., & Tang, Y. (2024). Puerarin attenuates osteoclastogenesis via regulation of FoxO1 signaling. Phytotherapy Research, 38(2), 845–856. https://doi.org/10.1002/ptr.8123

Firmenich, C. S., Schnepel, N., & Ranke, M. B. (2020). Insulin-like growth factor 1 in bone growth and development. Endocrine Reviews, 41(5), 625–649. https://doi.org/10.1210/endrev/bnaa015

Gan, J., Deng, X., Le, Y., Lai, J., & Liao, X. (2023). The development of naringenin for use against bone and cartilage disorders. Molecules, 28(9), 3716. https://doi.org/10.3390/molecules28093716

Guevara-Aguirre, J., Rosenbloom, A. L., & Savage, M. O. (2018). Growth hormone receptor deficiency. Endocrine Reviews, 39(5), 777–802. https://doi.org/10.1210/er.2018-00013

Han, X., Li, J., Wang, Y., & Zhang, H. (2024). Levistolide A promotes osteogenic differentiation and angiogenesis in bone marrow mesenchymal stem cells. Journal of Ethnopharmacology, 325, 116926. https://doi.org/10.1016/j.jep.2024.116926

Jian, L., Chen, Y., Wang, X., & Zhang, H. (2015). Calycosin-7-O-β-D-glucoside inhibits osteoclast differentiation and bone loss. International Journal of Molecular Medicine, 36(5), 1283–1291. https://doi.org/10.3892/ijmm.2015.2357

Lee, Y. L., Lin, Y. L., & Huang, H. C. (2014). Drynaria fortunei enhances bone formation through endochondral ossification. Journal of Ethnopharmacology, 155(3), 1333–1340. https://doi.org/10.1016/j.jep.2014.06.046

Liu, C. L., Wu, K. C., Lin, Y. L., & Huang, H. C. (2023). Ugonin L inhibits osteoclastogenesis via MAPK and NF-κB signaling pathways. Phytomedicine, 110, 154612. https://doi.org/10.1016/j.phymed.2022.154612

Liu, Y. Q., Hong, Z. L., & Zhang, L. (2016). Wedelolactone stimulates osteoblast differentiation and suppresses osteoclast formation. Bone, 87, 23–31. https://doi.org/10.1016/j.bone.2016.03.011

Liu, Z., Zhang, Y., & Li, Y. (2016). Osteocyte mechanotransduction and bone remodeling. Bone Research, 4, 16056. https://doi.org/10.1038/boneres.2016.56

Mohammadzadeh, M., Zarei, M., Abbasi, H., Webster, T. J., & Beheshtizadeh, N. (2024). Promoting osteogenesis and bone regeneration employing icariin-loaded nanoplatforms. Journal of Biological Engineering, 18(1), 25. https://doi.org/10.1186/s13036-024-00425-4

Moøller, N., & Joørgensen, J. O. L. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews, 30(2), 152–177. https://doi.org/10.1210/er.2008-0027

Qu, Y., Zhang, X., & Wang, J. (2022). Pharmacological activities of phthalides from Angelica sinensis. Phytochemistry Reviews, 21(3), 905–921. https://doi.org/10.1007/s11101-021-09774-9

Sherwood, L. (2016). Human physiology: From cells to systems (9th ed.). Cengage Learning.

Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., & Taniguchi, T. (2002). Induction and activation of the transcription factor NFATc1 in osteoclast differentiation. Developmental Cell, 3(6), 889–901. https://doi.org/10.1016/S1534-5807(02)00364-6

Wu, K. C., Lin, Y. L., & Huang, H. C. (2017). Flavonoids from Helminthostachys zeylanica with anti-osteoclastogenic activity. Journal of Natural Products, 80(8), 2373–2380. https://doi.org/10.1021/acs.jnatprod.7b00431

Xu, X., Zhang, P., & Wang, Y. (2017). Cistanoside A prevents bone loss by inhibiting osteoclast activity and promoting osteoblast differentiation. Phytomedicine, 34, 91–99. https://doi.org/10.1016/j.phymed.2017.07.015

Yakar, S., Rosen, C. J., & Beamer, W. G. (2018). Circulating levels of IGF-1 directly regulate bone growth

and density. Journal of Bone and Mineral Research, 33(6), 1135–1147. https://doi.org/10.1002/jbmr.3406

Yang, Y., Jing, Z., & Lv, J. (2020). Effects of ginsenosides on bone remodeling. Frontiers in Pharmacology, 11, 574. https://doi.org/10.3389/fphar.2020.00574

Yu, S., Yang, Y., & Li, X. (2020). Osthole enhances osteogenic differentiation via Wnt/β-catenin signaling. Phytotherapy Research, 34(6), 1360–1368. https://doi.org/10.1002/ptr.6601

Zhang, Z. R., Zhang, J. F., & Li, H. (2016). Osthole promotes endochondral ossification and fracture healing. Bone, 91, 77–89. https://doi.org/10.1016/j.bone.2016.07.019

Submitted

2024-12-11

Accepted

2026-06-02

Published

2026-06-30

Issue

Section

Articles